High-dose chemotherapy and autologous bone marrow transplantation (ABM
T) is now used routinely in an attempt to cure patients with poor-prog
nosis malignant diseases. This aggressive and intensive treatment requ
ires a highly trained health-care team. Nurses specializing in the car
e of these patients are essential to maintain patient well-being and e
nsure a good outcome. High-dose therapy leads to myelosuppression and
tissue damage, and the resultant infections, bleeding, and organ toxic
ities are frequently either unusual or more severe than those seen wit
h conventional-dose antineoplastic therapies. Organ toxicities can aff
ect both short-term and long-term functional status. Disabling or even
fatal consequences of treatment can occur during the transplant or mo
nths or years later. A specialized knowledge base and an understanding
of the way this therapy affects the patient is required not only for
the acute inpatient period, but also for the long term. A team approac
h to these complex patients with a central role for the nurse clinicia
n will lead to optimal patient care.